May 2011

Currently, more than 250 physicians and scientists work in concert to provide state-of- the art diagnosis, treatment, and aftercare for the more than 20,000 patients seen each year at the UW hospitals, clinics, and affiliate clinical facilities

Radiation therapy (RT) used in combination with hormonal approaches continues to be a viable strategy for treating localized, high-risk prostate cancer patients

Immunotherapies made headlines in oncology last month when the Centers for Medicare & Medicaid Services (CMS) decided that the anticancer vaccine sipuleucel-T (Provenge) will be a payable expense for prostate cancer.

Screening for prostate cancer does work, despite controversy about its efficacy

Therapies that target bone metastases have been developed for more than a decade.

Hormonal therapies have long been the standard of care for metastatic advanced prostate cancer

Increased prostate cancer screening has led to overtreatment and has not significantly reduced mortality rates in prostate cancer.

The Cancer Treatment Centers of America program will first be made available to patients with breast, colorectal, lung, and prostate cancers

Balloon kyphoplasty produces rapid pain relief and a better functional outcome than conventional nonsurgical management for painful VCFs in cancer patients

Patients with node-negative, locally advanced lung tumors who undergo induction chemoradiotherapy appear to survive significantly longer than patients who undergo surgical resection without induction chemoradiotherapy

According to the results of a recent study, fatigue and sleep disruption reduce neurocognitive function in adult survivors of childhood cancer

Investigators have documented a wide variation in the extent to which women with early-stage breast cancer worry about the possibility of recurrent disease

PROSTVAC-VF uses the smallpox viral vector to stimulate the immune system.

New data show that most prostate cancer patients who receive androgen-deprivation therapy gain a significant amount of weight within a year of starting treatment

New data suggested that hospitals that purchase a surgical robot experience a subsequent hike in the number of radical prostatectomies

Oncologist James Berenson, MD, likes all of his patients, especially the ones with whom he skis.

A Canadian study has found that a daily fish oil supplement can thwart chemotherapy-induced muscle and weight loss in lung cancer patients

Interview with Patricia Goldsmith the executive vice president and chief operating officer of the National Comprehensive Cancer Network (NCCN)

Each year the National Comprehensive Cancer Network (NCCN) presents the latest updates to its Clinical Practice Guidelines in Oncology, as well as the latest cancer therapies by key opinion leaders.

Patient advocacy and support groups for cancer patients come in all shapes and sizes. The list is long and encompasses many types of cancer, from the most common to the rare.

The explosion of knowledge emanating from laboratories and clinics across the globe is steadily clearing the "haze" that shrouds the molecular basis of malignant cell transformation, growth, and spread